Screener
BridgeBio Pharma BBIO Return on equity
Discontinued — last reported Q4 '20
Return on equity at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
Based on trailing twelve months.
The source filing: BridgeBio Pharma’s 10-K, filed February 23, 2023. Open the filing →
- Filed
- Feb 23, 2023
- Fiscal year
- FY2022
- Accession
- 0000950170-23-004145
FAQ
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.